Literature DB >> 15783125

Potassium metabolism in patients with chronic kidney disease (CKD), Part I: patients not on dialysis (stages 3-4).

Carlos G Musso1.   

Abstract

Potassium is the main cation in the intracellular space and its content in healthy adults is around 3700 mmol. Its retention is one of the dangers that accompanies chronic renal failure, especially when glomerular filtration rate (GFR) falls toward 20% of normal. There exist different mechanisms by which hyperkalemia is avoided in patients with renal failure. These include spontaneous restriction of dietary potassium intake to 40-60 mmol/day and aldosterone induced increase in potassium excretion in renal distal tubules and colonic epithelium. Although renal and intestinal adaptation are important in maintaining overall potassium balance during CKD, movement of potassium into the cells is extremely important in the body's acute defense against hyperkalemia, and occurs daily during postprandial potassium overload, through shift of this cation into hepatic cells mediated by insulin and thus avoiding post-prandial hyperkalemia. The above described mechanisms contribute to maintenance of normal serum potassium in patients with CKD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15783125     DOI: 10.1007/s11255-004-6193-z

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  4 in total

1.  Plasma aldosterone concentrations in chronic renal disease.

Authors:  R J Hené; P Boer; H A Koomans; E J Mees
Journal:  Kidney Int       Date:  1982-01       Impact factor: 10.612

Review 2.  Hyperkalemia in dialysis patients.

Authors:  J Ahmed; L S Weisberg
Journal:  Semin Dial       Date:  2001 Sep-Oct       Impact factor: 3.455

Review 3.  Treating interdialytic hyperkalemia with fludrocortisone.

Authors:  Louis J Imbriano; John H Durham; John K Maesaka
Journal:  Semin Dial       Date:  2003 Jan-Feb       Impact factor: 3.455

Review 4.  Hyperkalemia: An adaptive response in chronic renal insufficiency.

Authors:  F John Gennari; Alan S Segal
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

  4 in total
  7 in total

1.  Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus.

Authors:  Carlos G Musso; Matilde Navarro; Cesar Mombelli; Cora Giordani; Roxana Groppa; B Martinez; Raul De Miguel; Nora Imperiali
Journal:  Int Urol Nephrol       Date:  2012-12-13       Impact factor: 2.370

Review 2.  Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients.

Authors:  Carlos G Musso; Waldo H Belloso; Richard J Glassock
Journal:  World J Nephrol       Date:  2016-01-06

3.  Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.

Authors:  Sonal Korgaonkar; Anca Tilea; Brenda W Gillespie; Margaret Kiser; George Eisele; Fredric Finkelstein; Peter Kotanko; Bertram Pitt; Rajiv Saran
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

Review 4.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

5.  A Coaching Program to Improve Dietary Intake of Patients with CKD: ENTICE-CKD.

Authors:  Jaimon T Kelly; Marguerite Conley; Tammy Hoffmann; Jonathan C Craig; Allison Tong; Dianne P Reidlinger; Marina M Reeves; Kirsten Howard; Rathika Krishnasamy; Jagadeesh Kurtkoti; Suetonia C Palmer; David W Johnson; Katrina L Campbell
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-28       Impact factor: 8.237

6.  Sodium Excretion and the Risk of Cardiovascular Disease in Patients With Chronic Kidney Disease.

Authors:  Katherine T Mills; Jing Chen; Wei Yang; Lawrence J Appel; John W Kusek; Arnold Alper; Patrice Delafontaine; Martin G Keane; Emile Mohler; Akinlolu Ojo; Mahboob Rahman; Ana C Ricardo; Elsayed Z Soliman; Susan Steigerwalt; Raymond Townsend; Jiang He
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

7.  Major barriers responsible for malnutrition in hemodialysis patients: challenges to optimal nutrition.

Authors:  Maryam Ekramzadeh; Zohreh Mazloom; Peyman Jafari; Maryam Ayatollahi; Mohammad Mahdi Sagheb
Journal:  Nephrourol Mon       Date:  2014-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.